We found that SeP application might suppress the expression of Th17 cell-associated pro-inflammatory cytokines through the inactivation of NF-κB and MAPK pathways, thus improving the psoriasis-like skin inflammation. The gene discussed is NFKB1; the disease is dermatitis.